DEDASDecontamination Emulsion Direct Application System (disaster management)
References in periodicals archive ?
The DEDAS study was a multi-center, placebo-controlled, double-blind, randomized, dose-escalation Phase II trial conducted in 38 patients across 17 hospitals in the U.
Results from the recently completed DEDAS study, presented for the first time on February 4, 2005, as a late-breaker presentation at the 30th International Stroke Conference in New Orleans, Louisiana, showed trends indicating that desmoteplase administered intravenously in the time window up to nine hours after the onset of stroke symptoms:
are participating in a similar study, DEDAS (Dose Escalation study of Desmoteplase in Acute ischemic Stroke) to determine if they can replicate the successful DIAS results.